Navigation Links
Joseph Perrone Joins SRI International to Direct Molecular Diagnostics and Rare and Neglected Diseases Group
Date:11/11/2010

MENLO PARK, Calif., Nov. 11, 2010 /PRNewswire/ -- SRI International, an independent nonprofit research and development organization, announced today that Joseph Perrone, Sc.D., has joined SRI International's Center for Advanced Drug Research (CADRE) in Shenandoah Valley, Virginia. In his new role, Dr. Perrone will head CADRE's molecular diagnostic efforts, including its rare and neglected diseases program.

Dr. Perrone is an experienced marketing and business development executive who has led global teams and developed successful strategic alliances. His leadership guided a team to develop pioneering instrumentation and rapid diagnostic tests for infectious and tropical diseases. Additionally, Dr. Perrone opened new markets and developed a profitable international business throughout Africa, Asia, Latin America and Europe.

"Joe Perrone is an accomplished manager, with exceptional ability to work closely with public health programs and bridge the gap between marketing and scientific challenges," said Krishna Kodukula, Ph.D., CADRE executive director. "His results-oriented approach and significant experience building creative and innovative teams will be an asset to SRI."

Prior to joining SRI, Dr. Perrone served as president of JBP Consulting. His past experience includes serving as Vice President of Strategic Initiatives and Business Development at the American Association for Clinical Chemistry and Vice President of Standards, Certification, and Product Development at American Type Culture Collection.

Earlier, he was Vice President of the Technology Transfer Office at the University of Maryland Biotechnology Institute. Dr. Perrone previously served as the Director of Business Development and R&D Team Manager at Becton Dickinson, where he was responsible for the rapid manual test business, technology assessment, and clinical trials in international markets.

Dr. Perrone received his Sc.D. from Johns Hopkins University and completed a postdoctoral fellowship at Harvard University. He has served as an advisor to the World Health Organization (WHO) and on the WHO diagnostic steering committee. He has received numerous marketing awards, including the R&D 100 award. Dr. Perrone has also served on the boards of FASGen and Legacy Direct, and is an advisor to Instantlabs.

About SRI's Center for Advanced Drug Research (CADRE)

SRI established the Center for Advanced Drug Research (CADRE) to improve the productivity of the pharmaceutical industry, help our nation respond to biothreats, and develop life-saving treatments for rare and neglected diseases. CADRE's mission is to create new therapeutics, diagnostics, and vaccines for infectious and other diseases and for biodefense. CADRE combines and partners with SRI's well-established expertise in drug discovery, computational biology, and preclinical development with a new proteomics laboratory to develop these solutions.

About SRI's Biosciences Division

SRI's Biosciences division carries out basic research, drug discovery, and drug development, and provides contract (CRO) services. SRI has all of the resources necessary to take R&D from "Idea to IND"®—from initial discovery to the start of human clinical trials—and specializes in cancer, immunology and inflammation, infectious disease, and neuroscience. SRI's product pipeline has yielded marketed drugs, therapeutics currently in clinical trials, and additional programs in earlier stages. In its CRO business, SRI has helped government and commercial clients and partners advance many drugs into patient testing. SRI is also working to create the next generation of technologies in areas such as diagnostics, drug delivery, medical devices, and systems biology.

About SRI International

Silicon Valley-based SRI International is one of the world's leading independent research and technology development organizations. SRI, which was founded by Stanford University as Stanford Research Institute in 1946 and became independent in 1970, has been meeting the strategic needs of clients and partners for more than 60 years. Perhaps best known for its invention of the computer mouse and interactive computing, SRI has also been responsible for major advances in networking and communications, robotics, drug discovery and development, advanced materials, atmospheric research, education research, economic development, national security, and more. The nonprofit institute performs sponsored research and development for government agencies, businesses, and foundations. SRI also licenses its technologies, forms strategic alliances, and creates spin-off companies. In 2009, SRI's consolidated revenues, including its wholly owned for-profit subsidiary, Sarnoff Corporation, were approximately $470 million. Sarnoff Corporation, a leader in vision, video, and semiconductor innovations, will be fully integrated into SRI effective January 1, 2011.


'/>"/>
SOURCE SRI International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion
2. Speedus Engages Morgan Joseph to Evaluate Strategic Alternatives for Zargis Subsidiary
3. Dr. John Mills and Joseph Gentile Join Board of Directors of ChanTest Corporation
4. PDI Mourns Death of Board Member Dr. Joseph T. Curti
5. Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo
6. The Womens Heart Foundation Presents the Womens Heart Advocate Award for Medicine and Science to Multifunction CardioGram(TM) Inventor Dr. Joseph T. Shen
7. MoleSafe USA Expands Services to Leading Cancer Facilities at St. Josephs/Candler and CentraState Medical Center
8. Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
9. Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors
10. Joseph J. LaRosa Joins Nycomed US Inc.
11. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/27/2016)... KS (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com ... retailers of Eyeglasses . , Millions of individuals in the United States and ... have become a way to both correct vision and make a fashion statement. Even ...
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
Breaking Medicine News(10 mins):